Liselo Labs

Industry

Diagnostics, Feed, Industrial chemistry, Seeds & genetics, Veterinary

Topics

Synthetic biology platforms & biomanufacturing, Hybrid seeds & crop breeding

Role

Research / RTO — “…tive Learning Labs, Harvard University ( ) **Customers & partners** - Lesotho Department of Agriculture ( ) -…”

Why it is bioeconomy

Liselo Labs is a biotechnology and research company focused on vaccine manufacturing, diagnostics, and biologics development using converged NBIC technologies.

Found via

[Rubric] Eswatini · animal-vaccines

Products: Wildlife Research in Africa; Polyclonal IgY Antibodies; Recombinant Proteins; Antibody-based diagnostics and therapeutics; PCR diagnostics; Immunotherapeutic drug for COVID-19; VLP vaccines; Rotaviral infections pre-exposure prophylaxis; Cervical Cancer vaccines; Antivenoms and topical remedies

Certifications: Medical Devices Manufacturer Registered with SAPRHA

Applications

Therapeutic antibody production · Human therapeutics · Animal vaccine manufacture · Agricultural diagnostics · Veterinary therapeutics · Primary healthcare · disease management · pest management · identification · intervention management · reporting

Certifications (website)

Medical Devices Manufacturer Registered with SAPRHA

Customers & partners

Lesotho Department of Agriculture · North West Agriculture Department, South Africa · Biopharming Research Unit, University of Cape Town · Entomology Department, University of the North West · Centre for Nanoscale Systems, Harvard University · Central University of Technology, Free State · University of Kwa-Zulu Natal · Council for Scientific and Industrial Research (CSIR) · Imperial College London’s Chanjo Hub · NuGrainSA Consortium · developing world

Production sites

South Africa · Lesotho · Namibia · Botswana · Angola · Lesotho — cGMP capacity currently being expanded; Recombinant proteins · CSIR — Industrial scale; Novel, cost-effective manufacturing methods

Products (website)

Wildlife Research in Africa — Soft cover R280, ISBN number, Published by Fact and Faith Publications · Polyclonal IgY Antibodies — Custom polyclonal antibodies against a broad range of target antigens, generated within 6-12 weeks. · Recombinant Proteins — Plant-made recombinant proteins produced in N. benthamiana for human therapeutics and animal vaccine manufacture. · Antibody-based diagnostics and therapeutics — Range of antibody-based diagnostics and therapeutics targeting agricultural, veterinary, and primary healthcare challenges. · PCR diagnostics — Deployed across SADC in response to the COVID-19 pandemic. · Immunotherapeutic drug for COVID-19 — Candidate drug for severe COVID-19 cases and post-acute sequelae of SARS CoV-2. · VLP vaccines — African Horse Sickness Virus, Rift Valley Fever Virus, Influenza A and B vaccines. · Rotaviral infections pre-exposure prophylaxis — Candidate drug for prevention of rotaviral infections. · Cervical Cancer vaccines — Pre and post-exposure vaccination for cervical cancer. · Antivenoms and topical remedies — For venomous snakes of Southern Africa. · Antibiotic replacements — For animal feed. · _E.coli_ vaccine — For poultry.

Read from the company's own website: about · products · production · quality · rnd · leadership · contact · topic

• 2024-08 Latest status: The company has continued its research and development operations, including receiving new government funding in August 2024 and ethics committee registration in October 2024. ↗ ↗ ↗
• 2025-01-30 Plant-based vaccines could expand access across Africa | Imperial News | Imperial College London
  Liselo Labs, alongside Imperial College London and CSIR, is co-authoring and contributing to the effort to scale plant-based vaccine manufacturing from the lab to full-scale production, as part of the Chanjo Hub initiative.
• 2026-01-06 Southern Africa: A pragmatic reset to unlock South Africa–Taiwan tech cooperation - allAfrica.com
  Liselo Labs is a project or organization connected to empowering Africa’s growth, with leadership that emphasizes youth participation in Africa’s economic future and holds board roles (including on the BBBEE ICT Council) to advance ICT initiatives.
• 2025-01-30 Plant-based Vaccines Could Expand Access Across Africa | Mirage News
  Liselo Labs, represented by David Jarvis, is part of the international team advancing plant-based vaccine manufacture toward full-scale production, collaborating with Imperial’s Chanjo Hub to build manufacturing networks in Africa.
• 2026-01-13 Southern Africa: A pragmatic reset to unlock South Africa–Taiwan tech cooperation - News | Africa News
  Liselo Labs is mentioned as part of Liselo Labs? It refers to the person (likely a founder or executive) described as a South African entrepreneur involved in unlocking Africa’s growth potential, serving on multiple boards (including the BBBEE ICT Council and …
• 2025-04-08 Commercialization of a sorghum probiotic drink (Niselo) - Universities South Africa
  Niselo is a sorghum probiotic drink developed by Nutrigi (a Tshwane University of Technology startup) using a SANBio grant; it has been scaled for distribution in South Africa and Botswana, received international funding and recognition (Scottish Inward …
• 2026-09-23 SA’s HisWay Labs secures funding to help rebuild rail reliability - Disrupt Africa
  The article does not mention Liselo Labs at all; it focuses on HisWay Labs and its TrackView rail-integrity system securing funding and expanding internationally.

Ownership & investors 1

Partners & deals 5

Similar companies

Minapharm Pharmaceuticals · AGBL Group · Afrigen Biologics (Pty) Ltd · IQVIA Middle East and Africa · AGITECH · PHARAON HEALTHCARE AFRICA · Co-creation HUB (CcHUB) Limited · Gennecs Pharmaceuticals